1,2-dichloroethane increases expression ISO RGD:1317787 6480464 ethylene dichloride results in increased expression of TCF7L2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1317787 6480464 1, 2-Dimethylhydrazine results in decreased expression of TCF7L2 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1317786 6480464 Estradiol results in decreased expression of TCF7L2 mRNA CTD PMID:19167446 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of TCF7L2 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317787 6480464 Tetrachlorodibenzodioxin affects the expression of TCF7L2 mRNA CTD PMID:21570461 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TCF7L2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1317787 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TCF7L2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317787 6480464 Tetrachlorodibenzodioxin results in increased expression of TCF7L2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1317787 6480464 Tetrachlorodibenzodioxin results in decreased expression of TCF7L2 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1317786 6480464 Tetrachlorodibenzodioxin results in increased expression of TCF7L2 mRNA CTD PMID:19901195 2-hydroxypropanoic acid increases expression ISO RGD:1317786 6480464 Lactic Acid results in increased expression of TCF7L2 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine increases methylation ISO RGD:1317787 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased methylation of TCF7L2 promoter CTD PMID:26251327 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1317787 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of TCF7L2 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol affects expression ISO RGD:1317787 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of TCF7L2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1317787 6480464 Fenretinide results in decreased expression of TCF7L2 mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO RGD:1317787 6480464 Fluorouracil results in decreased expression of TCF7L2 mRNA, Fluorouracil results in decreased expression of TCF7L2 protein CTD PMID:25178657 5-fluorouracil multiple interactions ISO RGD:1317786 6480464 TCF7L2 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] CTD PMID:18678097 5-fluorouracil multiple interactions ISO RGD:1317787 6480464 [HDAC1 protein co-treated with HDAC2 protein] promotes the reaction [TCF7L2 protein inhibits the reaction [Fluorouracil results in decreased expression of MBP mRNA]] more ... CTD PMID:25178657 acrolein multiple interactions ISO RGD:1317786 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of TCF7L2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of TCF7L2 mRNA CTD PMID:32699268 afimoxifene increases expression ISO RGD:1317786 6480464 afimoxifene results in increased expression of TCF7L2 mRNA CTD PMID:19901195 aflatoxin B1 affects methylation ISO RGD:1317786 6480464 Aflatoxin B1 affects the methylation of TCF7L2 intron CTD PMID:30157460 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TCF7L2 mRNA CTD PMID:33354967 Aflatoxin B2 alpha affects methylation ISO RGD:1317786 6480464 aflatoxin B2 affects the methylation of TCF7L2 intron CTD PMID:30157460 AH23848 multiple interactions ISO RGD:1317786 6480464 [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased expression of TCF7L2 protein CTD PMID:19407222 all-trans-retinoic acid decreases expression ISO RGD:1317786 6480464 Tretinoin results in decreased expression of TCF7L2 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:1317786 6480464 Tretinoin results in increased expression of TCF7L2 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1317786 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of TCF7L2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of TCF7L2 mRNA CTD PMID:32699268 antirheumatic drug increases expression ISO RGD:1317786 6480464 Antirheumatic Agents results in increased expression of TCF7L2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1317786 6480464 aristolochic acid I results in decreased expression of TCF7L2 mRNA CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of TCF7L2 mRNA CTD PMID:34858468 arsenous acid increases expression ISO RGD:1317786 6480464 Arsenic Trioxide results in increased expression of TCF7L2 mRNA CTD PMID:20458559 benzo[a]pyrene increases expression ISO RGD:1317787 6480464 Benzo(a)pyrene results in increased expression of TCF7L2 mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:1317786 6480464 Benzo(a)pyrene affects the methylation of TCF7L2 intron CTD PMID:30157460 benzo[a]pyrene multiple interactions ISO RGD:1317787 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCF7L2 mRNA, AHR protein affects the reaction [Benzo(a)pyrene affects the expression of TCF7L2 mRNA] CTD PMID:22228805 , PMID:27858113 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1317786 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1317786 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 benzo[b]fluoranthene multiple interactions ISO RGD:1317787 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCF7L2 mRNA CTD PMID:27858113 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of TCF7L2 mRNA, [bisphenol A co-treated with Testosterone] results in increased expression of TCF7L2 mRNA CTD PMID:26496021 bisphenol A affects methylation ISO RGD:1317786 6480464 bisphenol A affects the methylation of TCF7L2 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1317787 6480464 bisphenol A results in increased expression of TCF7L2 mRNA CTD PMID:32365465 , PMID:34585602 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TCF7L2 mRNA CTD PMID:33296240 , PMID:34858468 bisphenol A decreases expression ISO RGD:1317787 6480464 bisphenol A results in decreased expression of TCF7L2 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of TCF7L2 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TCF7L2 mRNA CTD PMID:25181051 bisphenol F affects expression ISO RGD:1317787 6480464 bisphenol F affects the expression of TCF7L2 mRNA CTD PMID:30951980 bortezomib increases expression ISO RGD:1317786 6480464 Bortezomib results in increased expression of TCF7L2 mRNA CTD PMID:17895889 buta-1,3-diene decreases expression ISO RGD:1317787 6480464 1, 3-butadiene results in decreased expression of TCF7L2 mRNA CTD PMID:29038090 cadmium atom multiple interactions ISO RGD:1317786 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7L2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1317786 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of TCF7L2 mRNA CTD PMID:35301059 capecitabine multiple interactions ISO RGD:1317786 6480464 TCF7L2 results in decreased susceptibility to [Fluorouracil co-treated with Capecitabine] CTD PMID:18678097 carbamazepine affects expression ISO RGD:1317786 6480464 Carbamazepine affects the expression of TCF7L2 mRNA CTD PMID:24752500 , PMID:25979313 carbon nanotube decreases expression ISO RGD:1317787 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of TCF7L2 mRNA CTD PMID:34858468 choline multiple interactions ISO RGD:1317787 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TCF7L2 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TCF7L2 gene CTD PMID:20938992 chrysene multiple interactions ISO RGD:1317787 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCF7L2 mRNA CTD PMID:27858113 cisplatin decreases expression ISO RGD:1317786 6480464 Cisplatin results in decreased expression of TCF7L2 mRNA CTD PMID:21603599 , PMID:27392435 cisplatin multiple interactions ISO RGD:1317786 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of TCF7L2 mRNA more ... CTD PMID:27392435 clofibrate multiple interactions ISO RGD:1317787 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of TCF7L2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TCF7L2 mRNA] CTD PMID:17585979 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of TCF7L2 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1317786 6480464 [Chelating Agents binds to Copper] which results in decreased expression of TCF7L2 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1317786 6480464 [Chelating Agents binds to Copper] which results in decreased expression of TCF7L2 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:1317786 6480464 Copper Sulfate results in increased expression of TCF7L2 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1317787 6480464 Asbestos, Crocidolite results in decreased expression of TCF7L2 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of TCF7L2 mRNA CTD PMID:26577399 curcumin multiple interactions ISO RGD:1317786 6480464 Curcumin inhibits the reaction [CTNNB1 protein binds to TCF7L2 protein], Curcumin results in decreased activity of [CTNNB1 protein binds to TCF7L2 protein] CTD PMID:19294764 diarsenic trioxide increases expression ISO RGD:1317786 6480464 Arsenic Trioxide results in increased expression of TCF7L2 mRNA CTD PMID:20458559 diclofenac affects expression ISO RGD:1317786 6480464 Diclofenac affects the expression of TCF7L2 mRNA CTD PMID:24752500 dicrotophos increases expression ISO RGD:1317786 6480464 dicrotophos results in increased expression of TCF7L2 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1317786 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TCF7L2 mRNA CTD PMID:27188386 doxorubicin affects expression ISO RGD:1317787 6480464 Doxorubicin affects the expression of TCF7L2 protein CTD PMID:17415656 elemental selenium multiple interactions ISO RGD:1317786 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of TCF7L2 mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:1317786 6480464 Selenium results in decreased expression of TCF7L2 mRNA CTD PMID:19244175 epoxiconazole increases expression ISO RGD:1317787 6480464 epoxiconazole results in increased expression of TCF7L2 mRNA CTD PMID:35436446 folic acid multiple interactions ISO RGD:1317787 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TCF7L2 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TCF7L2 gene CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1317786 6480464 Formaldehyde results in decreased expression of TCF7L2 mRNA CTD PMID:20655997 furan decreases expression EXP 6480464 furan results in decreased expression of TCF7L2 mRNA CTD PMID:26194646 gallic acid decreases expression ISO RGD:1317786 6480464 Gallic Acid results in decreased expression of TCF7L2 mRNA CTD PMID:34408198 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of TCF7L2 mRNA CTD PMID:33387578 geraniol decreases expression ISO RGD:1317786 6480464 geraniol results in decreased expression of TCF7L2 mRNA CTD PMID:27683099 indometacin multiple interactions ISO RGD:1317786 6480464 Indomethacin inhibits the reaction [[CTNNB1 protein binds to TCF7L2 protein] which binds to CCND1 promoter] CTD PMID:11756231 irinotecan decreases expression ISO RGD:1317786 6480464 Irinotecan analog results in decreased expression of TCF7L2 mRNA CTD PMID:18927307 L-methionine multiple interactions ISO RGD:1317787 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TCF7L2 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of TCF7L2 gene CTD PMID:20938992 lead diacetate increases expression ISO RGD:1317787 6480464 lead acetate results in increased expression of TCF7L2 mRNA CTD PMID:36183778 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of TCF7L2 mRNA CTD PMID:24136188 leflunomide increases expression ISO RGD:1317786 6480464 leflunomide results in increased expression of TCF7L2 mRNA CTD PMID:28988120 lithium chloride multiple interactions ISO RGD:1317787 6480464 Lithium Chloride inhibits the reaction [TCF7L2 protein binds to GCG promoter], Lithium Chloride inhibits the reaction [TCF7L2 protein binds to GIP promoter] CTD PMID:19582394 menadione decreases expression ISO RGD:1317786 6480464 Vitamin K 3 results in decreased expression of TCF7L2 protein CTD PMID:31238027 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of TCF7L2 mRNA CTD PMID:30467583 Morroniside increases expression EXP 6480464 morroniside results in increased expression of TCF7L2 protein CTD PMID:24876057 N,N-dimethylaniline decreases expression ISO RGD:1317786 6480464 N more ... CTD PMID:21291235 N-methyl-4-phenylpyridinium increases expression ISO RGD:1317787 6480464 1-Methyl-4-phenylpyridinium results in increased expression of TCF7L2 mRNA CTD PMID:26558463 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of TCF7L2 mRNA CTD PMID:28801915 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1317786 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of TCF7L2 mRNA CTD PMID:24810058 nickel atom decreases expression ISO RGD:1317786 6480464 Nickel results in decreased expression of TCF7L2 mRNA CTD PMID:24768652 , PMID:25583101 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of TCF7L2 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of TCF7L2 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1317786 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of TCF7L2 mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RGD:1317786 6480464 Acetaminophen results in decreased expression of TCF7L2 mRNA CTD PMID:21420995 paracetamol multiple interactions ISO RGD:1317787 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of TCF7L2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of TCF7L2 mRNA] CTD PMID:17585979 phenobarbital affects expression ISO RGD:1317787 6480464 Phenobarbital affects the expression of TCF7L2 mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO RGD:1317787 6480464 pirinixic acid results in decreased expression of TCF7L2 mRNA CTD PMID:18445702 protein kinase inhibitor multiple interactions ISO RGD:1317786 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of TCF7L2 mRNA] CTD PMID:28003376 quercetin decreases expression ISO RGD:1317786 6480464 Quercetin results in decreased expression of TCF7L2 mRNA CTD PMID:19440933 rac-lactic acid increases expression ISO RGD:1317786 6480464 Lactic Acid results in increased expression of TCF7L2 mRNA CTD PMID:30851411 resveratrol decreases expression ISO RGD:1317786 6480464 resveratrol results in decreased expression of TCF7L2 protein CTD PMID:21291235 rotenone increases expression EXP 6480464 Rotenone results in increased expression of TCF7L2 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1317786 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of TCF7L2 mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:1317786 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TCF7L2 mRNA CTD PMID:27188386 selenium atom multiple interactions ISO RGD:1317786 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of TCF7L2 mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:1317786 6480464 Selenium results in decreased expression of TCF7L2 mRNA CTD PMID:19244175 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of TCF7L2 mRNA CTD PMID:32721576 silver atom decreases expression ISO RGD:1317787 6480464 Silver results in decreased expression of TCF7L2 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1317787 6480464 Silver results in decreased expression of TCF7L2 mRNA CTD PMID:27131904 sodium arsenite affects expression ISO RGD:1317786 6480464 sodium arsenite affects the expression of TCF7L2 mRNA CTD PMID:29319823 sodium arsenite decreases expression ISO RGD:1317787 6480464 sodium arsenite results in decreased expression of TCF7L2 mRNA CTD PMID:36209798 sodium arsenite decreases expression ISO RGD:1317786 6480464 sodium arsenite results in decreased expression of TCF7L2 mRNA CTD PMID:29301061 sodium dodecyl sulfate increases expression ISO RGD:1317786 6480464 Sodium Dodecyl Sulfate results in increased expression of TCF7L2 mRNA CTD PMID:31734321 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of TCF7L2 mRNA CTD PMID:26496021 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of TCF7L2 mRNA CTD PMID:33387578 tetraphene multiple interactions ISO RGD:1317787 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of TCF7L2 mRNA CTD PMID:27858113 titanium dioxide increases expression ISO RGD:1317786 6480464 titanium dioxide results in increased expression of TCF7L2 mRNA CTD PMID:34973136 toluene increases expression EXP 6480464 Toluene results in increased expression of TCF7L2 mRNA CTD PMID:22967744 topotecan affects expression EXP 6480464 Topotecan affects the expression of TCF7L2 mRNA CTD PMID:25729387 topotecan affects response to substance ISO RGD:1317786 6480464 TCF7L2 protein affects the susceptibility to Topotecan CTD PMID:16217747 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of TCF7L2 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:1317786 6480464 trichostatin A results in decreased expression of TCF7L2 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1317786 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TCF7L2 mRNA CTD PMID:27188386 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of TCF7L2 mRNA CTD PMID:30589522 triptonide affects expression ISO RGD:1317787 6480464 triptonide affects the expression of TCF7L2 mRNA CTD PMID:33045310 valproic acid affects expression ISO RGD:1317786 6480464 Valproic Acid affects the expression of TCF7L2 mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:1317786 6480464 Valproic Acid results in decreased methylation of TCF7L2 gene CTD PMID:28853863 , PMID:29201983 valproic acid decreases expression ISO RGD:1317786 6480464 Valproic Acid results in decreased expression of TCF7L2 mRNA CTD PMID:23179753 more ... vitamin E decreases expression ISO RGD:1317786 6480464 Vitamin E results in decreased expression of TCF7L2 mRNA CTD PMID:19244175 vitamin E multiple interactions ISO RGD:1317786 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of TCF7L2 mRNA CTD PMID:19244175